|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0630 AUD | -4.55% |
|
-4.55% | -25.88% |
| 12/06 | Neurizon Therapeutics Surpasses 50% Dosing Milestone in Trial of ALS Treatment | MT |
| 27/05 | Neurizon Therapeutics Limited Expands Regimen I of the Healey Als Platform Trial to 240 Participants | CI |
8001.Q_Cux3j5DLMI2wl2IoVj1BtpeaaHbbP7vJCMk9KltIg.BKjdlCChbfxrtGo6a-RRuUw6Pv_QJ4ef1aH__ODwwOUwk8a_Crw-8GWKRA~91108ba88f61d2767b9091de02354cac
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















